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Summary 
The cell surface of most Gram-negative bacteria is covered with lipopolysaccharides (LPS). The 
network of charges and sugars provided by the dense packing of LPS molecules in the outer leaflet of 
the outer membrane interferes with the entry of hydrophobic compounds into the cell, including 
many antibiotics. In addition, LPS can be recognized by the immune system and play a crucial role in 
many interactions between bacteria and their animal hosts. LPS is synthesized in the inner membrane 
of Gram-negative bacteria, so it must be transported across their cell envelope to assemble at the cell 
surface. Over the last two decades, much of the research on LPS biogenesis has focused on the 
discovery and understanding of Lpt, a multi-protein complex that spans the cell envelope and 
functions to transport LPS from the inner membrane to the outer membrane.  This chapter focuses on 
the early steps of the transport of LPS by the Lpt machinery: the extraction of LPS from the inner 
membrane. The following chapter describes the subsequent steps as LPS travels through the 
periplasm and the outer membrane to its final destination at the cell surface.      
 
Introduction 
All cells are defined by a cellular envelope that directly contacts the outside world and whose 
integrity is required for cell survival. Consequently, the fate of a cell in any given environment is 
greatly determined by the architecture and composition of its cell envelope. The bacterial cell 
envelope can contain one or two membranes termed monoderm and diderm respectively. The major 
type of diderm bacteria are the so-called Gram negatives. The unique structure and composition of 
the Gram-negative cell envelope allows the survival of these single-cell organisms in many different 
environments. This mainly depends on the ability of their cell envelope to selectively allow the entry 
of useful molecules such as nutrients, while preventing the entry of harmful ones including many 
antibiotics.   
The Gram-negative cell envelope consists of two lipid bilayers each with distinct composition 
and permeability properties. These two membranes are separated by an aqueous compartment, 
termed the periplasm, and a cell-wall polymer composed of peptidoglycan [1]. The inner membrane 
(IM), which surrounds the cytoplasm, is a typical phospholipid bilayer, while the outer membrane 
(OM), which is the outermost cell boundary, is asymmetric with phospholipids in the inner leaflet 
and lipopolysaccharides (LPS) in the outer leaflet. Most of what is known and what we will discuss 
about the OM comes from studying Escherichia coli and Salmonella typhimurium. However, it is 
unclear how representative this is of most Gram negatives. LPS is an amphipathic molecule 
composed of lipid A, a core oligosaccharide, and a long polysaccharide commonly called O antigen 
(Fig. 1). Although the overall structure and properties of LPS are conserved, its chemical 
composition varies among species [2, 3]. In fact, some bacteria synthesize a shorter version of LPS 
known as lipooligosaccharide or LOS [2]. In addition to the lipid asymmetry conferred by the 
presence of LPS (or LOS) in the outer leaflet, the OM is structurally different from the IM in that its 
integral OM proteins adopt a β-barrel conformation instead of the typical α-helical structure of 
integral IM proteins. Both LPS and β-barrel proteins contribute to the unique permeability properties 
of the OM. Molecules of LPS pack tightly in the outer leaflet of the OM and the hydrophilicity of its 
sugars and charges of its  phosphates serve as a barrier to small hydrophobic compounds that 
normally partition and diffuse through phospholipid bilayers like the IM. In contrast, many small 
hydrophilic molecules can easily cross the OM by diffusing through the hydrophilic lumen of porins– 
integral β-barrel proteins that function as nonspecific, ungated pores or sieves [4]. As the IM lacks 
ungated pores, entry of small hydrophilic molecules through the IM relies on transporters that must 
recognize them to allow their transport into the cytoplasm. Therefore, many molecules that can 
diffuse across the IM (small hydrophobic compounds) cannot easily penetrate through the OM 
because of LPS, and many molecules that can diffuse across the OM (small hydrophilic compounds) 
cannot easily penetrate through the IM. The fact that these two membranes have opposite 
permeability properties protects cells from many harmful compounds and is one of the major reasons 
why it is so difficult to develop antibiotics that are effective against Gram-negative bacteria.  
The importance of LPS in providing resistance against hydrophobic antibiotics was revealed 
from studies of wild-type cells where LPS was removed by chemical treatment or of mutant cells 
defective in LPS biogenesis [4, 5]. Collectively, these studies demonstrated that decreasing the 
amount of LPS at the cell surface leads to the appearance or an increase of phospholipids at the cell 
surface. When phospholipids are present in the outer leaflet, the asymmetry of the OM is broken, 
effectively creating patches of phospholipid bilayer, which allow the diffusion of small hydrophobic 
compounds into the cell. Indeed, a decrease in the levels of LPS at the cell surface leads to 
hypersensitivity to hydrophobic toxic molecules such as bile salts and some antibiotics. Furthermore, 
these studies also revealed that some bacterial species such as Escherichia coli, Salmonella 
typhimurium, and Pseudomonas aeruginosa cannot survive without LPS, while others such as 
Neisseria meningitidis, Acinetobacter baumannii and Moraxella catarrhalis can [6-11]. Therefore, it 
is crucial that, during growth at each cell cycle, Gram-negative bacteria properly assemble millions 
of LPS molecules at their cell surface at a speed estimated to be as high as 70,000 molecules/min [3].  
For more than 40 years, we have known that although LPS must be present at the cell surface, 
its synthesis occurs at the IM [12, 13]. In the last two decades, the players involved in the transport of 
LPS across the cell envelope have been identified. This review and the accompanying piece [14] 
highlight the research that has led to our current understanding of how, following synthesis at the 
inner leaflet of the IM, LPS is flipped across the IM, extracted from the IM, transported across the 
aqueous periplasm, and translocated through the OM so that it can finally assemble at the cell surface 
(Fig. 1). This chapter focuses on the early steps that take place at the IM in the journey of LPS across 
the cell envelope. The following chapter will delve into the details of LPS transport across the 
periplasm and insertion into the OM [14]. 
 
Synthesis, transport, and biogenesis of the LPS layer     
Electron microscopy studies drove the discovery that the Gram-negative cell envelope is 
delimited by two membranes [15]. Electron micrographs produced by Kellenberger and Ryter were 
the first to clearly distinguish that there were three layers in the E. coli cell envelope [16]. The 
chemical composition of these multilayers took some time to describe. Bladen and Mergenhagen 
found that the outer layer of the Gram-negative Veillonella bacterium could be extracted with phenol-
water and that the extracted material retained the endotoxic effects associated with LPS [17]. The 
intermediate layer could be broken down by lysozyme indicating that it was peptidoglycan [17]. Thus 
it was soon deduced that Gram-negative bacteria have an inner and outer lipid membrane with 
peptidoglycan in between them. The asymmetric nature of the OM was demonstrated by two seminal 
studies. Muhlradt and Golecki showed that LPS was on the cell surface by immuno-electron 
microscopy, while Kamio and Nikaido found that the main OM phospholipid, phosphatidyl-
ethanolamine, was not accessible to external modification and thus not on the bacterial surface [13, 
18].  
Around the same time, studies on the synthesis of LPS led to the ground-breaking realization 
that LPS synthesis takes place at the IM. The development of fractionation methods by Miura and 
Mizushima to separate the IM and OM by density allowed Osborn and collaborators to show that 
although the majority of LPS resides in the OM, it is synthesized at the IM [12, 19, 20]. This study 
was pivotal, as it provided the first evidence that LPS must be transported across the cell envelope. 
Muhlradt et al. further showed that all synthesis steps occur at the IM before transport [21]. Both of 
these studies also demonstrated an important point: transport of LPS to the cell surface is irreversible.  
Extensive studies on the biosynthesis of LPS, led mainly by Christian Raetz and 
collaborators, culminated in the elucidation of the synthesis pathway, which revealed that the lipid A-
core subunit of LPS is synthesized at the cytoplasmic side of the IM [3, 22]. We now also know that 
the O antigen is synthesized independently of lipid A-core and that its ligation to the lipid A-core, as 
well as other LPS modifications, occur at the periplasmic side of the IM [2, 22, 23]. Together, these 
works broke the ground for studies of the transport of LPS across the cell envelope. They also 
indicated that LPS localization to the OM requires at least two distinct steps: flipping of lipid A-core 
across the IM and transport of fully synthesized LPS across the periplasm to the OM.  Because most 
of the studies on LPS transport across the cell envelope have been conducted in cells that do not 
synthesize O antigen, we will only describe hereafter the transport of the lipid A-core subunit, which, 
for simplicity, we will refer to as LPS.   
 
MsbA flips LPS across the IM 
Georgopoulos and collaborators discovered the LPS flippase MsbA in a genetic screen as a 
multicopy suppressor of the temperature-sensitive allele of htrB [24]. Discovery that HtrB, renamed 
LpxL, is a lauroyl acyltransferase involved in the synthesis of LPS  led researchers to propose that 
MsbA was a transporter of lipid A because it belongs to the ATP-binding cassette (ABC) family of 
proteins [25, 26]. Polissi, together with Georgopoulos, Raetz, and collaborators, quickly followed up 
by demonstrating that MsbA is involved in transport of newly synthesized LPS to the OM [27, 28]. 
The function as a flippase was finally verified by Doerrler et al. by demonstrating that modification 
of LPS with aminoarabinose and phosphoethanolamine, which occurs at the outer leaflet of the IM, is 
dependent on MsbA [29].  
The flipping mechanism of MsbA has received ample focus and it has become a model to 
study structural changes that ABC exporters undergo during transport. As in other ABC transporters, 
ATP hydrolysis provides the energy for MsbA function [27, 30]. Structural studies have 
demonstrated that MsbA forms a homodimer with fused nucleotide binding and transmembrane 
domains (NBD and TMD respectively) [31]. Further, x-ray crystallography has revealed multiple 
conformations of MsbA including two inward-facing states where the NBDs undergo a large 
conformational change (Fig. 2A) [31]. A ~50Å movement of the NBDs suggests that these domains 
readily separate and dimerize possibly to allow substrate to enter the lumen of the transporter [31].   
These conformational changes of MsbA have been recently studied in a membrane mimicking 
environment by single particle electron microscopy that captured MsbA in a continuum of 
conformations. The separation of the NBDs was consistent with the range reported in crystal 
structures (40-85Å) and the majority of MsbA molecules without ATP were in a closed to moderately 
open state (40-60Å) [32]. Furthermore, there is in vivo evidence of this conformational change. Using 
fluorescence resonance energy transfer, Doshi and van Veem have shown that binding of lipid A 
induces NBDs dimerization and stimulates ATP hydrolysis [33]. Structural studies have also revealed 
that ATP hydrolysis promotes transition to an outward-facing conformation accompanied by a 
twisting of the transmembrane domains (Fig. 2B) [31]. This conformational change is thought to 
insert lipid A into the outer leaflet of the IM. Despite the tour de force of structural work on MsbA, 
mechanistic details of flipping remain unclear.  
Interestingly, MsbA has been implicated as a multidrug transporter as well [34]. Lipid A and 
amphipathic drugs can bind MsbA at the same time, suggesting that MsbA has separate binding sites 
for these two types of substrates [35]. These multiple roles in antibiotic resistance and LPS transport 
make MsbA a great target for future antibiotic design. 
 
Debate over intermembrane structures as a means of transport of OM components from the 
IM to the OM 
Once LPS is flipped by MsbA across the IM, it must be transported across the cell envelope. 
Transport of lipids and proteins from the IM to the OM could be thought to occur in three 
biologically relevant ways: vesicular transport, diffusion at sites of fusion between the two 
membranes, or protein mediated transport. Eukaryotic systems have evidence of all three types of 
transport mechanisms being involved in lipid transport between organelles [36].  
To investigate cell envelope structure and biogenesis in bacteria, early research took 
advantage of the powerful technique of electron microscopy. No visual evidence of vesicles in the 
periplasm was ever observed, but some groups reported areas of adhesion between the IM and OM 
noticeable upon plasmolysis [37]. These were first described by Manfred Bayer for whom they were 
named Bayer bridges. Their description started a long debate about whether or not they were 
physiologically relevant. Some groups argued that the observed structures are artefacts of certain 
techniques for fixing cells [38]. Meanwhile, Bayer and colleagues argued that they are sensitive 
structures broken in harsher preparations [39].  Some support was given to the transport of LPS 
through Bayer bridges when Muhlradt et al. demonstrated that newly synthesized LPS appeared at 
distinct locations in the OM that often overlapped with Bayer bridge structures [21].  
We now know that LPS transport occurs through proteinaceous bridges that extend from the 
cytoplasm to the OM [40-43]. The first evidence of this type of transport was provided by 
Tommassen and collaborators, who showed that LPS transport can still occur in spheroplasts that 
maintain IM-OM contacts and that are devoid of periplasmic contents [43]. The proteins involved in 
LPS transport that form these bridges have been named Lpt and they will be the focus of the 
remaining discussion of this piece and the accompanying chapter [14]. Whether Lpt bridges 
correspond to some of the controversial Bayer bridges remains unknown. 
 
The Lpt bridge 
Lpt proteins (LptA through LptG) transport LPS from the IM to the OM. Although 
experimentally Lpt has been studied most extensively in E. coli, this LPS transporter is thought to be 
structurally and functionally conserved among LPS producers [44, 45]. The seven Lpt factors form 
an eight-member multi-protein complex (LptAB2CDEFG) that spans from the cytoplasm to the OM 
(Fig. 1). Knowledge about the sub-cellular location of each Lpt protein and the steps required for 
transport has guided most of the models about how Lpt functions. After LPS is flipped across the IM 
by MsbA, the cell needs to extract the glycolipid from the outer leaflet of the IM, transport it across 
the aqueous periplasm and the OM, and assemble it at the outer leaflet of the OM. Consequently, 
each of these stages in LPS transport have been respectively attributed to those factors localized at 
the IM, periplasm, and OM.  
The IM sub-complex consists of LptB2CFG and is responsible for the extraction of LPS from 
the IM. LptB is a cytoplasmic protein belonging to the ABC transporter NBD family that associates 
as a dimer with IM proteins LptCFG [40, 46, 47]. LptFG are polytopic integral IM proteins that 
constitute the TMD subunits of the LptB2FG ABC transporter [48]. LptC has a single transmembrane 
anchor in the IM and a large periplasmic domain that is structurally homologous to both LptA and the 
periplasmic domain of LptD [40]. As described below, in our current model, the LptB2FG ABC 
transporter harnesses energy from ATP hydrolysis to power the extraction of LPS from the outer 
leaflet of the IM and load the glycolipid onto LptC.   
Transit of LPS through the periplasm is mediated through structurally homologous domains 
found in LptC, LptA, and LptD. LptA physically connects LptC at the IM and the LptDE sub-
complex at the OM [41]. LptA is the only component that completely resides in the periplasm, 
although LptC can function without its membrane anchor [49, 50]. Kahne and collaborators have 
proposed that LPS travels as a stream through the Lpt system and that when a new LPS molecule is 
loaded onto the Lpt bridge by LptB2FG, it pushes LPS molecules that were already ahead of it, 
causing forward movement towards the OM [42].  
Translocation of LPS across the OM and its assembly at the cell surface are mediated by the 
LptDE OM sub-complex. LptD has two essential domains: an N-terminal periplasmic domain and C-
terminal β-barrel [51]. LptE is a lipoprotein that resides within the lumen of the LptD barrel [51, 52]. 
As discussed in detail in the accompanying chapter [14], recent studies support a model where LPS 
arrives at the periplasmic domain of LptD and is guided by LptE through LptD so that it can be 
delivered at the outer leaflet of the OM [45, 53, 54]. 
In vivo studies have demonstrated that depletion of any one Lpt protein shuts down transport 
of LPS in E. coli, which leads to the accumulation of large membrane structures presumably 
protruding from the IM into the periplasm [48, 55]. In addition, the fact that the LPS molecules that 
accumulate at the IM can be modified with colanic acid by WaaL at the periplasmic leaflet of the IM 
demonstrates that Lpt functions after MsbA flips LPS across the IM [48, 55]. Together, these data 
and the biochemical evidence demonstrating that all proteins physically interact to form a complex 
support the model described in Fig. 1.  
 
Discovery of the Lpt extraction machinery LptB2FGC 
Three decades after realizing that LPS must be transported from the IM to the OM, the 
players involved began to be identified. The Polissi group identified the first IM components of the 
Lpt system using a genetic screen designed to find essential genes. Serina et al. identified one 
essential operon that contains yrbG (still uncharacterized), kdsDC (Kdo biosynthesis genes, at the 
time named yrbHI), and lptCAB (at the time named yrbK and yhbNG, respectively) [56]. These 
studies showed that at least lptAB were essential.  
In follow-up studies, Polissi and collaborators established the role of LptAB in LPS transport. 
Because altered expression of lptAB can lead to increased sensitivity to hydrophobic toxic 
compounds or death, they proposed that these factors were essential proteins involved in OM 
biogenesis [57]. Just as decades before the use of ultracentrifugation to separate the IM and OM led 
to the discovery that radiolabelled, newly synthesized LPS must be transported to the OM after its 
synthesis at the IM, this analytical technique was crucial to demonstrate that depletion of either LptA 
or LptB leads to accumulation of newly synthesized LPS at the IM [58].  
Noting these phenotype were similar to those of depleting LptDE, the Polissi and Silhavy 
laboratories joined forces to demonstrate that, indeed, depletion of each LptABDE and newly 
characterized LptC resulted in the same phenotypes[55, 58-60]. This suggested that Lpt factors 
function together. Having identified an Lpt protein in every compartment of the cell suggested a 
model where LptB was a cytoplasmic ATPase that provided the energy source for transport, LptA 
was a chaperone that shuttled LPS across the periplasm, and the OM complex of LptDE functioned 
as a receptor/insertase for LPS.  
Sequence analysis clearly predicted LptB as the NBD of an ABC transporter; however, the 
identity of its TMD partners was uncertain because the IM protein LptC only has a single 
transmembrane helix and ABC transporters typically have eight to twelve transmembrane helices 
[61]. Identification of the missing TMDs was accomplished by Ruiz et al. through a reductionist 
bioinformatics approach that took advantage of the essentiality of LPS transport. The group searched 
for predicted envelope proteins shared by E. coli and an endosymbiotic, LPS producing relative that 
has undergone massive reduction of its genome size[48]. Among the resulting proteins, they searched 
for those predicted to be essential and of unknown function in E. coli, and they identified YjgPQ 
[48]. Because each was predicted to have a 6-transmembrane helical structure typical of ABC 
transporter TMDs, and their depletion resulted in phenotypes that resembled those reported for the 
depletion of Lpt factors, YjgPQ were renamed LptFG and proposed to be the missing TMD of the 
LptB2FG ABC transporter [48].  
 
Function of Lpt at the IM: energetics of transport  
Without the Lpt complex, LPS accumulates at the outer leaflet of the IM; therefore, the first 
step in LPS transport is the extraction of the glycolipid from this leaflet (Fig. 1) [48, 55]. LptFGC are 
positioned to be the likely extractors since LPS resides in the outer leaflet of the IM; the fact that 
LptB was predicted to be an ATPase suggested early on that ATP hydrolysis is likely the energy 
source to power extraction [48, 55]. This model raises the fundamental question of how the energy 
derived from ATP hydrolysis is transmitted across the IM so that extraction of LPS can occur. Most 
known ABC transporters translocate substrates across membranes [61]. The fact that this ABC 
transported extracts a substrate from the membrane suggests a novel mechanism of action.  
To begin to answer this question, the organization of the IM complex was first studied by 
Narita and Tokuda, who overexpressed and copurified the complex using a polyhistidine tag on LptB 
[46]. Size-exclusion chromatography demonstrated that complexes of LptBFGC have a 2:1:1:1 
subunit ratio [46].  This was also in agreement with the mechanism of ABC transporters that usually 
contain a dimer of NBDs [61]. A further advance in our understanding of the LptB2FG complex was 
recently made by the Ruiz and Kahne laboratories. Using a combination of structural, biochemical, 
and genetic approaches, Sherman et al. have shown that LptB variants defective in either ATP 
hydrolysis or interactions with LptFG cannot support growth, demonstrating that LptB must 
hydrolyse ATP and interact with LptFG to function in LPS transport [47]. Furthermore, X-ray crystal 
structures of LptB in ATP- and ADP- bound states have suggested that conformational changes 
associated with ATP hydrolysis occur in a groove in the LptB dimer that lines the membrane 
interface that interacts with LptFG (Fig. 3) [47]. We have proposed that these structural changes 
reveal the means of coupling ATP hydrolysis by LptB to the extraction of LPS by the IM components 
[47].  
The action of the LptB2FG ABC transporter is intimately related to the transport of LPS along 
the periplasmic components of Lpt. So far the energetics of LPS flow has been studied for movement 
along the Lpt bridge from LptC to LptA. Whitfield and collaborators have co-purified His-tagged 
LptC with LPS [50]. Addition of LptA to their system resulted in the transfer of LPS from LptC to 
LpA but not vice versa, suggesting that differences in binding affinity of Lpt factors and LPS could 
be part of the driving force for LPS transport across the periplasm [50]. More recently, Okuda et al. 
have demonstrated that ATP hydrolysis is required for LPS movement along the bridge [42]. Using 
site-specific photoactivatable cross-linking in a right-side-out vesicle system, the Kahne laboratory 
has demonstrated that LPS interacts with specific residues within the hydrophobic grooves of LptC 
and LptA [42]. Importantly, cross-linking of LPS to LptC and subsequent transfer of LPS from LptC 
to LptA was found to be dependent on ATP hydrolysis [42]. These results have led to the model 
presented in Fig. 1, where LPS moves in a step-wise and ATPase-driven fashion from protein to 
protein across the Lpt bridge.  
 
Mechanism of extraction and unknown roles for LptFG 
Currently, the first protein in the Lpt bridge known to interact with the substrate LPS is 
LptC[42, 50]. Interestingly, the aforementioned study by Okuda et al. also demonstrated that LptC 
cannot extract LPS on its own [42]. Extraction and handing off LPS to the bridge could be thought to 
occur by one of two mechanisms. In one model, LptFG could interact directly with LPS, performing 
the extraction function coupled to LptB’s ATP hydrolysis. Somehow they would then have to pass 
LPS to LptC. In this model, both LptF and LptG or just one of them could interact with LPS. The 
other model proposes that, in an ATP-dependent manner, LptFG somehow stimulate LptC to extract 
LPS from the IM. At this moment, LptFG are the most poorly understood components of the Lpt 
system. Additional work is needed to understand their essential function in LPS transport.  
 
Conclusion 
A large body of research conducted in the last two decades has finally made great progress in 
elucidating how the glycolipid LPS is transported from its site of synthesis, the IM, to its final 
location, the cell surface. This progress was possible by the use of many different in vivo, in vitro, 
and in silico approaches and the efforts of many laboratories. The following chapter resumes the 
discussion about the major discoveries that have been made regarding the periplasmic and OM 
components of the Lpt system. Despite all this progress, more research is still needed to understand 
the mechanism of transport and assembly of the Lpt bridge, and how the cell coordinates LPS 
transport with other processes that are required for proper envelope biogenesis [62, 63].  
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Figure and table captions 
Figure 1. Transport of LPS across the cell envelope.  Following synthesis, LPS (lipid A-core 
oligosaccharide) molecules are flipped across the IM in an ATP-dependent manner by MsbA. At the 
outer leaflet, the O antigen is ligated to the outer core to form full-length LPS (not shown). LPS is 
transported across the periplasm and OM, and assembled at the cell surface by LptB2FGCADE. 
LptB2FG form an ABC transporter that utilizes ATP hydrolysis to extract LPS from the IM and push it 
along a periplasmic bridge built of homologous domains in LptCAD. It is unclear whether LptF, LptG, 
or both, interact with LptC. At the OM, the LptDE form a plug-and-barrel translocon that inserts LPS 
into the outer leaflet. Structural composition of E. coli LPS is shown on the left. Kdo=3-deoxy-D-
manno-oct-2-ulosonic acid, Hep=L-glycero-D-manno-heptose, Etn=ethanolamine, P=phosphate, 
Glu=D-glucose, Gal=D-galactose. 
 
Figure 2. MsbA undergoes structural conformational changes proposed to mediate LPS flipping. A. Crystal 
structures of MsbA (monomers in blue and cyan) suggest that the NBDs readily separate and dimerize in its 
inward facing state (PDB accession number: 3B5W, 3B5X) [31]. B. MsbA bound to a non-hydrolyzable ATP 
analog (AMPPNP in yellow spheres) shows an outward facing state and associated twisting of the 
transmembrane helices (PDB accession number: 3B5X, 3B5Y) [31]. 
 
Figure 3. Structures of LptB reveal site of interaction with TMD partners and conformational changes induced 
by ATP hydrolysis. A. Crystal structure of the LptB dimer (monomers in dark and light gray, nucleotides in 
yellow spheres) shows the groove (highlighted in brown) that is involved in interactions with LptFG at the 
membrane interface (symmetry mate derived from PDB accession number: 4P33) [47]. B. Superimposed 
structures of an ATP-bound (green) and an ADP-bound (blue) LptB monomer show conformational changes 
associated with ATP hydrolysis (PDB accession number: 4P32, 4P33)[47]. 
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